In re Narconon Drug Rehabilitation Marketing, Sales Practices & Products Liability Litigation

84 F. Supp. 3d 1367, 2015 U.S. Dist. LEXIS 14292, 2015 WL 506365
CourtUnited States Judicial Panel on Multidistrict Litigation
DecidedFebruary 5, 2015
DocketMDL No. 2598
StatusPublished

This text of 84 F. Supp. 3d 1367 (In re Narconon Drug Rehabilitation Marketing, Sales Practices & Products Liability Litigation) is published on Counsel Stack Legal Research, covering United States Judicial Panel on Multidistrict Litigation primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Narconon Drug Rehabilitation Marketing, Sales Practices & Products Liability Litigation, 84 F. Supp. 3d 1367, 2015 U.S. Dist. LEXIS 14292, 2015 WL 506365 (jpml 2015).

Opinion

ORDER DENYING TRANSFER

SARAH S. VANCE, Chairman.

Before the Panel:

Free access — add to your briefcase to read the full text and ask questions with AI

Related

In Re Eli Lilly & Co.(cephalexin Monohydrate)
446 F. Supp. 242 (Judicial Panel on Multidistrict Litigation, 1978)
In re Signal International LLC Human Trafficking Litigation
38 F. Supp. 3d 1390 (Judicial Panel on Multidistrict Litigation, 2014)

Cite This Page — Counsel Stack

Bluebook (online)
84 F. Supp. 3d 1367, 2015 U.S. Dist. LEXIS 14292, 2015 WL 506365, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-narconon-drug-rehabilitation-marketing-sales-practices-products-jpml-2015.